{"id":790886,"date":"2024-11-26T13:03:45","date_gmt":"2024-11-26T18:03:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-advances-fight-against-breast-cancer-with-fda-cleared-next-generation-ai-solutions-and-a-second-read-ai-partnership-with-cascaid-health-at-rsna-2024\/"},"modified":"2024-11-26T13:03:45","modified_gmt":"2024-11-26T18:03:45","slug":"icad-advances-fight-against-breast-cancer-with-fda-cleared-next-generation-ai-solutions-and-a-second-read-ai-partnership-with-cascaid-health-at-rsna-2024","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-advances-fight-against-breast-cancer-with-fda-cleared-next-generation-ai-solutions-and-a-second-read-ai-partnership-with-cascaid-health-at-rsna-2024\/","title":{"rendered":"iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024"},"content":{"rendered":"

\nProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients \u2013 Launching Q1 2025
\n<\/h2>\n
\n

NASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) — iCAD, Inc<\/a>. (NASDAQ: ICAD) (\u201ciCAD\u201d or the \u201cCompany\u201d), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5.<\/p>\n

Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research presentations, and a new partnership with Cascaid Health to expand access to AI-driven breast health solutions.<\/p>\n

\n iCAD and Cascaid Health Partner to Expand Access to AI-Driven Breast Health<\/strong>\n <\/p>\n

In alignment with their vision to enable all women to access to AI-powered breast health services, iCAD and Cascaid Health will unveil their collaboration to integrate the ProFound AI Breast Health Suite into Cascaid\u2019s leading edge digital health marketplace and access to care platform. Scheduled for beta launch in Q1 2025, this partnership between iCAD and Cascaid Health will launch ProFound Health, a virtual care model powered by Cascaid. ProFound will enable women who have not otherwise received an AI-read on their screening mammogram to access iCAD\u2019s advanced breast health technology. The initiative reflects both companies\u2019 dedication to democratizing access to life-saving technology and creating a world where cancer can\u2019t hide.<\/p>\n

ProFound Health will offer a \u201cSecond Read\u201d virtual AI service, providing patients without access to AI an opportunity to receive enhanced breast health insights. The initial service will include second-read detection, breast density assessment, and cancer risk evaluation from a Cascaid-affiliated specialist network of clinical experts in women\u2019s health through Cascaid\u2019s seamlessly integrated digital platform. By combining AI insights with expert clinical reviews, ProFound Health ensures that patients everywhere, regardless of location, can receive precision screening and personalized care.<\/p>\n

\u201cProFound Health empowers patients with access to critical information about their mammograms and overall breast health, allowing them to make informed decisions and take control of their care journey,\u201d said Dana Brown, CEO and President of iCAD. \u201cOur collaboration with Cascaid Health\u2019s network of clinicians and AI-powered solutions is part of our ongoing commitment to bridging gaps in breast cancer care, ensuring all patients everywhere can access the accuracy and timeliness of AI solutions, and ultimately transforming patient outcomes.\u201d<\/p>\n

\u201cWe believe that every woman should have access to the best possible information about her breast health and a high quality, personalized care plan to catch cancer early or prevent it altogether. Through our partnership with iCAD, we\u2019re addressing a critical need to improve access to advanced breast health services,\u201d said Dr. Candace Westgate, Director of Women\u2019s Health for Cascaid Health. \u201cProFound Health is more than just a technological innovation, it\u2019s a lifeline that empowers patients and healthcare providers with actionable insights, bridging care gaps and ensuring equitable access to precision screening and personalized breast cancer care.\u201d<\/p>\n

\n Advancing Next Generation AI Breast Health Solutions at RSNA 2024<\/strong>\n <\/p>\n

In addition to ProFound Health, iCAD will feature its flagship ProFound Detection Version 4.0, which recently received FDA clearance. This next-generation AI solution enhances breast cancer detection by incorporating prior exams into current analysis, improving the detection of aggressive cancers by 22%, reducing cases with no marks by 18%, and providing clinicians with more reliable insights for better decision-making. <\/p>\n

\u201cEvery two minutes, someone loses their life to breast cancer\u2014a disease affecting over 2.3 million women annually. Early detection is critical, as five-year survival rates exceed 99% for stage 1 disease. Yet traditional mammography misses over 20% of breast cancers, particularly in dense tissue, resulting in potentially avoidable late-stage diagnoses,\u201d said Dana Brown, President and CEO of iCAD, Inc. \u201cProFound Detection Version 4 revolutionizes breast cancer detection by uniquely integrating prior exams into its analysis. This advanced capability enhances sensitivity, sharpens precision, and provides radiologists with a deeper, longitudinal view of a patient\u2019s breast health. By enabling earlier and more accurate detection, especially in dense tissue, ProFound Detection Version 4 sets a new standard in breast health AI, empowering providers to improve outcomes and save lives. Together with our strategic partnerships, we are advancing the fight against cancer and making a meaningful difference for patients worldwide.\u201d<\/p>\n

\n ICAD\u2019S RSNA 2024 Program Highlights<\/strong>\n <\/p>\n

\n AI-Powered Insights: Advancing Cancer Detection<\/strong>\n <\/p>\n